JP2001509814A - 4−アミノアルコキシ−1h−ベンゾイミダゾール誘導体、それらの調製およびそれらのドパミン自己受容体(d▲下2▼)作動薬としての使用 - Google Patents
4−アミノアルコキシ−1h−ベンゾイミダゾール誘導体、それらの調製およびそれらのドパミン自己受容体(d▲下2▼)作動薬としての使用Info
- Publication number
- JP2001509814A JP2001509814A JP53572798A JP53572798A JP2001509814A JP 2001509814 A JP2001509814 A JP 2001509814A JP 53572798 A JP53572798 A JP 53572798A JP 53572798 A JP53572798 A JP 53572798A JP 2001509814 A JP2001509814 A JP 2001509814A
- Authority
- JP
- Japan
- Prior art keywords
- ethyl
- trifluoromethyl
- yloxy
- pharmaceutically acceptable
- benzyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/10—Radicals substituted by halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80127697A | 1997-02-18 | 1997-02-18 | |
US08/801,276 | 1997-02-18 | ||
PCT/US1998/000613 WO1998035945A1 (en) | 1997-02-18 | 1998-01-13 | 4-aminoalkoxy-1h-benzimidazole derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2001509814A true JP2001509814A (ja) | 2001-07-24 |
Family
ID=25180658
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP53572798A Pending JP2001509814A (ja) | 1997-02-18 | 1998-01-13 | 4−アミノアルコキシ−1h−ベンゾイミダゾール誘導体、それらの調製およびそれらのドパミン自己受容体(d▲下2▼)作動薬としての使用 |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0973749A1 (xx) |
JP (1) | JP2001509814A (xx) |
KR (1) | KR20000071129A (xx) |
CN (1) | CN1252793A (xx) |
AR (1) | AR011136A1 (xx) |
AU (1) | AU746717B2 (xx) |
BR (1) | BR9807701A (xx) |
CA (1) | CA2278700A1 (xx) |
HU (1) | HUP0001302A3 (xx) |
IL (1) | IL131158A0 (xx) |
NZ (1) | NZ336969A (xx) |
TW (1) | TW513415B (xx) |
WO (1) | WO1998035945A1 (xx) |
ZA (1) | ZA981309B (xx) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009096806A (ja) * | 2002-03-05 | 2009-05-07 | Transtech Pharma Inc | リガンドのrageとの相互作用を阻害する単環式および二環式アゾール誘導体 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6541502B1 (en) * | 2001-07-20 | 2003-04-01 | Wyeth | 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta[a]-naphthalenyl derivatives with antipsychotic activity |
US8580833B2 (en) | 2009-09-30 | 2013-11-12 | Transtech Pharma, Inc. | Substituted imidazole derivatives and methods of use thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4704390A (en) * | 1986-02-13 | 1987-11-03 | Warner-Lambert Company | Phenyl and heterocyclic tetrahydropyridyl alkoxy-benzheterocyclic compounds as antipsychotic agents |
ATE210657T1 (de) * | 1994-10-14 | 2001-12-15 | Merck Patent Gmbh | Zns wirksames (r)-(-)-2-(5-(4-fluorophenyl)-3- pyridylmethylaminomethyl)chroman |
ZA9610745B (en) * | 1995-12-22 | 1997-06-24 | Warner Lambert Co | 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists |
JP2000516936A (ja) * | 1996-08-27 | 2000-12-19 | アメリカン・ホーム・プロダクツ・コーポレイション | ドパミンd2作動薬としておよび5―ht1aリガンドとしての4―アミノエトキシインドール |
-
1998
- 1998-01-13 AU AU59153/98A patent/AU746717B2/en not_active Ceased
- 1998-01-13 IL IL13115898A patent/IL131158A0/xx unknown
- 1998-01-13 BR BR9807701-5A patent/BR9807701A/pt not_active IP Right Cessation
- 1998-01-13 JP JP53572798A patent/JP2001509814A/ja active Pending
- 1998-01-13 KR KR1019997007418A patent/KR20000071129A/ko not_active Application Discontinuation
- 1998-01-13 NZ NZ336969A patent/NZ336969A/xx unknown
- 1998-01-13 CN CN98804249A patent/CN1252793A/zh active Pending
- 1998-01-13 EP EP98902513A patent/EP0973749A1/en not_active Withdrawn
- 1998-01-13 CA CA002278700A patent/CA2278700A1/en not_active Abandoned
- 1998-01-13 HU HU0001302A patent/HUP0001302A3/hu unknown
- 1998-01-13 WO PCT/US1998/000613 patent/WO1998035945A1/en not_active Application Discontinuation
- 1998-02-03 TW TW087101275A patent/TW513415B/zh active
- 1998-02-11 AR ARP980100617A patent/AR011136A1/es not_active Application Discontinuation
- 1998-02-17 ZA ZA9801309A patent/ZA981309B/xx unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009096806A (ja) * | 2002-03-05 | 2009-05-07 | Transtech Pharma Inc | リガンドのrageとの相互作用を阻害する単環式および二環式アゾール誘導体 |
Also Published As
Publication number | Publication date |
---|---|
IL131158A0 (en) | 2001-01-28 |
KR20000071129A (ko) | 2000-11-25 |
BR9807701A (pt) | 2000-05-02 |
CN1252793A (zh) | 2000-05-10 |
HUP0001302A2 (hu) | 2001-05-28 |
AU746717B2 (en) | 2002-05-02 |
WO1998035945A1 (en) | 1998-08-20 |
TW513415B (en) | 2002-12-11 |
ZA981309B (en) | 1999-08-17 |
CA2278700A1 (en) | 1998-08-20 |
HUP0001302A3 (en) | 2001-07-30 |
EP0973749A1 (en) | 2000-01-26 |
AU5915398A (en) | 1998-09-08 |
NZ336969A (en) | 2001-03-30 |
AR011136A1 (es) | 2000-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103189337A (zh) | 氨基二氢化茚衍生物、包含所述氨基二氢化茚衍生物的药物组合物及其在治疗中的用途 | |
JP2000516936A (ja) | ドパミンd2作動薬としておよび5―ht1aリガンドとしての4―アミノエトキシインドール | |
EP1831195A1 (en) | 5-ht7 receptor antagonists | |
NZ551509A (en) | Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics | |
PL186885B1 (pl) | Pochodne indoliny użyteczne jako antagoniści receptora 5-HT-2C | |
US6342498B1 (en) | Arylpiperazines as serotonin reuptake inhibitors and 5-HT1Dα antagonists | |
JP2001509814A (ja) | 4−アミノアルコキシ−1h−ベンゾイミダゾール誘導体、それらの調製およびそれらのドパミン自己受容体(d▲下2▼)作動薬としての使用 | |
US6127380A (en) | 4-aminoalkoxy-1H-benzoimidazoles | |
EP1630158A1 (en) | 5-HT7 receptor antagonists | |
US5990144A (en) | 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one dopamine autoreceptor agonists | |
JP2001511803A (ja) | 4−アミノアルコキシ−1,3−ジヒドロベンゾイミダゾール−2−チオン誘導体、それらの調製およびそれらのドパミン自己受容体(d▲下2▼)作動薬としての使用 | |
US5972958A (en) | 4-aminoalkoxy-1,3-dihydro-benzoimidazol-2-thiones | |
JP2001511805A (ja) | ドパミン作動薬である5−アミノアルコキシ−1,4−ジヒドロキノキサリン−2,3−ジオン | |
JPH10203987A (ja) | (r)−1−エチル−4−メチルヘキサヒドロ−1h−1,4−ジアゼピン誘導体を有効成分とするモルヒネ様薬剤誘発嘔吐抑制剤 | |
JP2001511804A (ja) | 4−アミノアルコキシ−1,3−ジヒドロベンゾイミダゾール−2−オン誘導体、それらの調製およびそれらのドパミン自己受容体(d▲下2▼)作動薬としての使用 | |
MXPA99007585A (en) | 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one derivatives, theirpreparation and their use as dopamine autoreceptor (d2) agonists | |
US5922715A (en) | 5-aminoalkoxy-1, 4-dihydroquinoxaline-2, 3-diones | |
JP2002511450A (ja) | 4−アミノ−(エチルアミノ)−オキソインドールドパミン自己受容体作動薬 | |
MXPA99007586A (en) | 4-aminoalkoxy-1h-benzimidazole derivatives, their preparation and their use as dopamine autoreceptor (d2 | |
EP1676840A1 (en) | 5-HT7 Receptor antagonists | |
MXPA99007587A (en) | 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-thiones derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists | |
MXPA99007593A (en) | 5-aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists | |
PL166800B1 (pl) | Sposób wytwarzania nowych pochodnych Indolu | |
PL166799B1 (pl) | Sposób wytwarzania nowych pochodnych Indolu |